Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Will Ashworth

AbbVie’s Call Action Suggests It Might Just Be a Buy

Nothing about Abbvie’s (ABBV) share volume indicates investors were either enthusiastic or pessimistic about its stock on Wednesday. 

The maker of Humira, the company’s blockbuster rheumatoid arthritis drug, had a total volume yesterday of a little more than four million shares, one-third less than its 30-day average. It ended up less than 1% higher on the day.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.